Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Novello

Showing results (851-860 of 1,095) with videos related to

Pageof 110
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 20, 2022
Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancersAnne Mc Leer, Matthieu Foll, Marie Brevet, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 17, 2021
IκBα targeting promotes oxidative stress-dependent cell deathGiovanna Carrà, Giuseppe Ermondi, Chiara Riganti, et al.
Briefings in Functional Genomics & Proteomics|June 9, 2007
The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresisDaniel Martins-de-Souza, Daniel Martins, Bruno Menezes de Oliveira, et al.
Cancer Treatment Reviews|March 14, 2025
The evolving landscape of stage III unresectable non-small cell lung cancer "between lights and shadows"Marco Donatello Delcuratolo, Veronica Crespi, Giorgio Saba, et al.
Cancer|July 2, 2003
Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational StudyFederico Cappuzzo, Giovanni Selvaggi, Vanesa Gregorc, et al.
Oncology and Therapy|June 11, 2025
Impact of Tumor Response and Response Duration on Survival Among Participants Receiving Pembrolizumab Plus Chemotherapy as First-Line Therapy for Non-Small-Cell Lung CancerMarina C Garassino, Ying Cheng, Delvys Rodriguez-Abreu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 23, 2017
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant TreatmentSara Pilotto, Isabella Sperduti, Giovanni Leuzzi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 26, 2024
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomesLuca Bertolaccini, Antonino Carmelo Tralongo, Marzia Del Re, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2023
Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerDario P Anobile, Iris C Salaroglio, Fabrizio Tabbò, et al.
Scientific Reports|April 22, 2016
Centennial-scale solar forcing of the South American Monsoon System recorded in stalagmitesValdir F Novello, Mathias Vuille, Francisco W Cruz, et al.
Pageof 110

Showing results (851-860 of 1,095) with videos related to

Sort By:
Pageof 110
Lung Cancer (Amsterdam, Netherlands)|February 20, 2022
Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancersAnne Mc Leer, Matthieu Foll, Marie Brevet, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 17, 2021
IκBα targeting promotes oxidative stress-dependent cell deathGiovanna Carrà, Giuseppe Ermondi, Chiara Riganti, et al.
Briefings in Functional Genomics & Proteomics|June 9, 2007
The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresisDaniel Martins-de-Souza, Daniel Martins, Bruno Menezes de Oliveira, et al.
Cancer Treatment Reviews|March 14, 2025
The evolving landscape of stage III unresectable non-small cell lung cancer "between lights and shadows"Marco Donatello Delcuratolo, Veronica Crespi, Giorgio Saba, et al.
Cancer|July 2, 2003
Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational StudyFederico Cappuzzo, Giovanni Selvaggi, Vanesa Gregorc, et al.
Oncology and Therapy|June 11, 2025
Impact of Tumor Response and Response Duration on Survival Among Participants Receiving Pembrolizumab Plus Chemotherapy as First-Line Therapy for Non-Small-Cell Lung CancerMarina C Garassino, Ying Cheng, Delvys Rodriguez-Abreu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 23, 2017
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant TreatmentSara Pilotto, Isabella Sperduti, Giovanni Leuzzi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 26, 2024
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomesLuca Bertolaccini, Antonino Carmelo Tralongo, Marzia Del Re, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2023
Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerDario P Anobile, Iris C Salaroglio, Fabrizio Tabbò, et al.
Scientific Reports|April 22, 2016
Centennial-scale solar forcing of the South American Monsoon System recorded in stalagmitesValdir F Novello, Mathias Vuille, Francisco W Cruz, et al.
Pageof 110